Novel method of endoscopic ultrasound‐guided hepaticogastrostomy to prevent stent dysfunction. Issue 10 (October 2014)

• Record Type: Journal Article
• Authors: Ogura, Takeshi; Kurisu, Yoshitaka; Masuda, Daisuke; Imoto, Akira; Hayashi, Michihiro; Malak, Mohamed; Umegaki, Eiji; Uchiyama, Kazuhisa; Higuchi, Kazuhide
• Is Part Of: Journal of gastroenterology and hepatology. Volume 29:Issue 10(2014:Oct.)
• Page Start: 1815
• Page End: 1821
• Publication Date: 2014-10
• Subjects: Gastroenterology -- Periodicals; Digestive organs -- Diseases -- Periodicals; Liver -- Diseases -- Periodicals; Gastroenterology -- Periodicals; Liver Diseases -- Periodicals; 616.33
• DOI: 10.1111/jgh.12598
• Languages: English
• ISSNs: 0815-9319

Abstract

<abstract abstract-type="main"> <title>Abstract</title> <sec id="jgh12598-sec-0001" sec-type="section"> <title>Background and Study Aim</title> <p>The present study assesses the feasibility as well as the technical and functional success rates of a novel endoscopic ultrasound‐guided hepaticogastrostomy (EUS‐HGS) technique called the locking stent method that uses end‐bare covered metallic stents (EBCMS).</p> </sec> <sec id="jgh12598-sec-0002" sec-type="section"> <title>Methods</title> <p>Twenty consecutive patients who were histologically diagnosed with unresectable cancer complicated with obstructive jaundice underwent EUS‐HGS due to failed endoscopic biliary drainage or inaccessible papilla. We retrospectively collected clinical data for these patients including technical and functional success rates and complications.</p> </sec> <sec id="jgh12598-sec-0003" sec-type="section"> <title>Results</title> <p>Seven were treated by EUS‐HGS (EUS‐HGS group), and 13 were treated using the locking stent EUS‐HGS method (LS group). Technical and functional success rates were 100% in both groups. Procedural duration did not significantly differ between the EUS‐HGS and LS groups (26.9 ± 9.0 <italic>versus</italic> 32.3 ± 11.1 min, <italic>P</italic> = 0.30). Two patients developed complications related to stent migration in the EUS‐HGS group. In contrast, although mild post‐procedural bile peritonitis required conservative treatment for a few days, none of the stents malfunctioned in the LS group.</p> </sec> <sec id="jgh12598-sec-0004" sec-type="section"> <title>Conclusion</title> <p>Our method can safely and effectively prevent stent dysfunction, but validation in a prospective clinical trial is required.</p> </sec> </abstract>